HIV care in Central and Eastern Europe: How close are we to the target

被引:39
|
作者
Gokengin, Deniz [1 ]
Oprea, Cristiana [2 ]
Begovac, Josip [3 ]
Horban, Andrzej [4 ]
Zeka, Arzu Nazli [5 ]
Sedlacek, Dalibor [6 ]
Allabergan, Bayjanov [7 ]
Almamedova, Esmira A. [8 ]
Balayan, Tatevik [9 ]
Banhegyi, Denes [10 ]
Bukovinova, Pavlina [11 ]
Chkhartishvili, Nikoloz [12 ]
Damira, Alymbaeva [13 ]
Deva, Edona [14 ]
Elenkov, Ivaylo [15 ]
Gashi, Luljeta [16 ]
Gexha-Bunjaku, Dafina [16 ]
Hadciosmanovic, Vesna [17 ]
Harxhi, Arjan [18 ]
Holban, Tiberiu [19 ]
Jevtovic, Djorje [20 ]
Jilich, David [21 ,22 ]
Kowalska, Justyna [4 ]
Kuvatova, Djhamal [13 ]
Ladnaia, Natalya [23 ]
Mamatkulov, Adkhamjon [7 ]
Marjanovic, Aleksandra [24 ]
Nikolova, Maria [25 ]
Poljak, Mario [26 ]
Ruutel, Kristi [27 ]
Shunnar, Azzaden [11 ]
Stevanovic, Milena [28 ]
Trumova, Zhanna [29 ]
Yurin, Oleg [23 ]
机构
[1] Ege Univ Izmir, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
[2] Carol Davila Univ Med & Pharm, Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania
[3] Univ Zagreb, Sch Med, Univ Hosp Infect Dis, Zagreb, Croatia
[4] Med Univ Warsaw, Hosp Infect Dis Warsaw, Warsaw, Poland
[5] Yunus Emre State Hosp, Eskisehir, Turkey
[6] Charles Univ Prague, Med Fac, Dept Infect & Travellers Dis, Plzen, Czech Republic
[7] Minist Publ Hlth Uzbekistan, Inst Virol, Tashkent, Uzbekistan
[8] AIDS Control Ctr, Baku, Azerbaijan
[9] Natl Ctr Dis Control & Prevent Armenia, Yerevan, Armenia
[10] Szent Laszlo Hosp, Budapest, Hungary
[11] Univ Hosp, Ctr HIV AIDS, Clin Infect Dis, Bratislava, Slovakia
[12] AIDS & Clin Immunol Res Ctr, Infect Dis, Tbilisi, Georgia
[13] Kyrgyz Russian Slavonic Univ, Dept Infect Dis, Div Med, Bishkek, Kyrgyzstan
[14] Community Dev Fund, Prishtina, Kosovo
[15] Specialized Hosp Act Treatment Infect & Parasit D, Sofia, Bulgaria
[16] Natl Inst Publ Hlth Kosovo, Prishtina, Kosovo
[17] Univ Sarajevo, Clin Ctr, Infect Dis Clin, Sarajevo, Bosnia & Herceg
[18] Univ Hosp Ctr Tirana, Fac Med, Infect Dis Dept, Tiran, Albania
[19] State Med & Pharmaceut Univ Nicolae Testemitanu, Dept Infect Dis & Med Parasitol, Kishinev, Moldova
[20] Univ Belgrade, Sch Med, Infect & Trop Dis Hosp, HIV AIDS Unit,Clin Ctr Serbia, Belgrade, Serbia
[21] Charles Univ Prague, Fac Med 1, Dept Infect & Trop Dis, Prague, Czech Republic
[22] Na Bulovce Hosp, Prague, Czech Republic
[23] Russian Fed AIDS Ctr, Cent Sci Res Inst Epidemiol Rospotrebnadzor, Moscow, Russia
[24] Inst Publ Hlth, Podgorica, Montenegro
[25] Natl Ctr Infect & Parasit Dis, Natl Reference Lab Immunol, Sofia, Bulgaria
[26] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia
[27] Natl Inst Hlth Dev, Tallinn, Estonia
[28] Clin Infect Dis & Febrile Condit, Skopje, North Macedonia
[29] Kazakh Natl Med Univ, Dept HIV Infect & Infect Control, Alma Ata, Kazakhstan
关键词
HIV care; Central Europe; Eastern Europe; 90-90-90n targets; MEN;
D O I
10.1016/j.ijid.2018.03.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this survey was to describe the current status of HIV care in the countries of Central and Eastern Europe and to investigate how close the region is to achieving the UNAIDS 2020 target of 9090-90. Methods: In 2014, data were collected from 24 Central and Eastern European countries using a 38-item questionnaire. Results: All countries reported mandatory screening of blood and organ donors for HIV. Other groups subjected to targeted screening included people who inject drugs (PWID) (15/24, 62.5%), men who have sex with men (MSM) (14/24, 58.3%), and sex workers (12/24, 50.0%). Only 14 of the 24 countries (58.3%) screened pregnant women. The percentages of late presentation and advanced disease were 40.3% (range 14-80%) and 25.4% (range 9-50%), respectively. There was no difference between countries categorized by income or by region in terms of the percentages of persons presenting late or with advanced disease. The availability of newer antiretroviral drugs (rilpivirine, etravirine, darunavir, maraviroc, raltegravir, dolutegravir) tended to be significantly better with a higher country income status. Ten countries reported initiating antiretroviral therapy (ART) regardless of CD4+ T cell count (41.7%), five countries (20.8%) used the threshold of <500 cells/mu l, and nine countries (37.5%) used the threshold of <350cells/ mu I. Initiation of ART regardless of the CD4+ T cell count was significantly more common among highincome countries than among upper-middle-income and lower-middle-income countries (100% vs. 27.3% and 0%, respectively; p = 0.001). Drugs were provided free of charge in all countries and mostly provided by governments. There were significant discrepancies between countries regarding the follow-up of people living with HIV. Conclusions: There are major disparities in the provision of HIV care among sub-regions in Europe, which should be addressed. More attention in terms of funding, knowledge and experience sharing, and capacity building is required for the resource-limited settings of Central and Eastern Europe. The exact needs should be defined and services scaled up in order to achieve a standard level of care and provide an adequate and sustainable response to the HIV epidemic in this region. (C) 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 50 条
  • [1] HIV Infection in Turkey: How Close Are We to the Target?
    Gokengin, Deniz
    KLIMIK JOURNAL, 2018, 31 (01) : 4 - 10
  • [2] How close are we to hepatitis C virus elimination in Central Europe?
    Flisiak, Robert
    Frankova, Sona
    Grgurevic, Ivica
    Hunyady, Bela
    Jarcuska, Peter
    Kupcinskas, Limas
    Makara, Michael
    Simonova, Marieta
    Sperl, Jan
    Tolmane, Ieva
    Vince, Adriana
    Zarebska-Michaluk, Dorota
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (01) : 1 - 8
  • [3] HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?
    Kowalska, J. D.
    Skrzat-Klapaczynska, A.
    Bursa, D.
    Balayan, T.
    Begovac, J.
    Chkhartishvili, N.
    Gokengin, D.
    Harxhi, A.
    Jilich, D.
    Jevtovic, D.
    Kase, K.
    Lakatos, B.
    Matulionyte, R.
    Mulabdic, V
    Nagit, A.
    Papadopoulos, A.
    Stefanovic, M.
    Vassilenko, A.
    Vasylyev, M.
    Yancheva, N.
    Yurin, O.
    Horban, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 311 - 314
  • [4] HIV in central and eastern Europe
    Hamers, FF
    Downs, AM
    LANCET, 2003, 361 (9362): : 1035 - 1044
  • [5] The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group
    Skrzat-Klapaczynska, Agata
    Kowalska, Justyna D.
    Afonina, Larisa
    Antonyak, Svitlana
    Balayan, Tatevik
    Begovac, Josip
    Bursa, Dominik
    Dragovic, Gordana
    Gokengin, Deniz
    Harxhi, Arjan
    Jilich, David
    Kase, Kerstin
    Lakatos, Botond
    Mardarescu, Mariana
    Matulionyte, Raimonda
    Oprea, Cristiana
    Panteleev, Aleksandr
    Papadopoulos, Antonios
    Sojak, Lubomir
    Tomazic, Janez
    Vassilenko, Anna
    Vasylyev, Marta
    Verhaz, Antonija
    Yancheva, Nina
    Yurin, Oleg
    Horban, Andrzej
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (13)
  • [6] Institutional care in Central and Eastern Europe
    Mansell, Jim
    TIZARD LEARNING DISABILITY REVIEW, 2010, 15 (02) : 2 - +
  • [7] The HIV Epidemic in Eastern Europe and Central Asia
    Jack DeHovitz
    Anneli Uuskula
    Nabila El-Bassel
    Current HIV/AIDS Reports, 2014, 11 : 168 - 176
  • [8] HIV/AIDS crisis in Central and Eastern Europe
    不详
    JOURNAL OF ADVANCED NURSING, 2002, 40 (05) : 491 - 491
  • [9] The HIV Epidemic in Eastern Europe and Central Asia
    DeHovitz, Jack
    Uuskula, Anneli
    El-Bassel, Nabila
    CURRENT HIV/AIDS REPORTS, 2014, 11 (02) : 168 - 176
  • [10] An overview of HIV prevention in central and eastern Europe
    Danziger, R
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1996, 8 (06): : 701 - 707